Health Canada has not approved BPC-157 as a health product, and the compound exists in a legal gray area in Canada
TB-500 TB-500 (43 amino acids): A synthetic analog of Thymosin Beta-4 (T4), investigated for its influence on cell migration, motility, and tissue regeneration
Dosing protocols and administration How you take a compound matters almost as much as what the compound does
Don't forget the essentials The **BPC-157 + TB-500 10mg** combo delivers in a single vial the two most extensively studied tissue regeneration peptides in musculoskeletal research: **5 mg of BPC-157** (Body Protection Compound-157, a 15-amino-acid pentadecapeptide derived from human gastric juice, isolated by Predrag Sikiric's team at Zagreb from the 1990s) paired with **5 mg of TB-500** (active fragment of thymosin beta-4 described by Allan Goldstein in 1981, 44-residue ubiquitous regeneration peptide)
Together, these peptides provide a framework for examining how coordinated signaling pathways influence movement-associated response dynamics and tissue-level communication
